CAS 899805-25-5

CB30865

CAS : 899805-25-5

CB30865

Formule : C₂₆H₂₂BrN₅O₂

Degré de pureté : ≥98%

Masse moléculaire : 516.39

Ref: 54-BUP20579

Tanzisertib

CAS : 899805-25-5

Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.

Formule : C₂₁H₂₃F₃N₆O₂

Degré de pureté : 98.66% - 99.28%

Couleur et forme : Solid

Masse moléculaire : 448.44

Ref: TM-T14895

CC 930

CAS : 899805-25-5

Formule : C₂₁H₂₃F₃N₆O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 448.4415

Ref: IN-DA00GU2C

Tanzisertib

CAS : 899805-25-5

Tanzisertib

Formule : C₂₁H₂₃F₃N₆O₂

Degré de pureté : ≥98%

Couleur et forme : Solid

Masse moléculaire : 448.44

Ref: 54-BUP15237

Tanzisertib

CAS : 899805-25-5

Tanzisertib is a small molecule that is being studied for the treatment of cancer. It has been shown to inhibit the phosphorylation of c-jun and collagen, which are proteins that play an important role in the development of cardiac disease. Tanzisertib inhibits the binding of a number of protein inhibitors, such as erythropoietin receptor (EPOR), epidermal growth factor receptor (EGFR), and vascular endothelial growth factor receptor 2 (VEGFR2). This drug also has immunomodulatory effects, which may be due to its ability to inhibit the production of inflammatory cytokines. Tanzisertib has been shown to inhibit tumor cell proliferation by inhibiting protein synthesis and cell division, which may lead to tumor shrinkage.

Formule : C₂₁H₂₃F₃N₆O₂

Degré de pureté : Min. 95%

Masse moléculaire : 448.44 g/mol

Ref: 3D-FT74805